Ovarian Cancer Coverage From Every Angle
Advertisement
Advertisement

Robert L. Coleman, MD, on Secondary Surgical Cytoreduction Followed by Chemotherapy for Ovarian Cancer

Posted: Wednesday, June 6, 2018

Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, discusses phase III study findings on secondary surgical cytoreduction followed by platinum-based combination chemotherapy, with or without bevacizumab, in platinum-sensitive, recurrent ovarian cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.